STAT | Reporting from the frontiers of health and medicine Follow Opinion: Drug developers shouldn’t shortchange the autoimmune community “How a company treats its clinical trial pioneers is a litmus test for corporate social responsibility,” writes Nkarta CEO Paul J. Hastings. https://www.statnews.com/2025/10/13/clinical-trials-autoimmune-disorders-crohns-lupus-nkarta/ statnews.com
